Neuroprotective effect of β-lapachone in MPTP-induced parkinson’s disease mouse model: Involvement of astroglial p-AMPK/Nrf2/HO-1 signaling pathways

Medicine and Dentistry

• Nuclear Factor 100%
• Prothrombin 100%
• Cell Signaling Pathway 100%
• MPTP-induced Parkinsonism 100%
• Adenosine Phosphate 100%
• Neuroprotective Agent 100%
• Protein Kinases 100%
• 1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine 66%
• Astrocyte 50%
• Tyrosine 3 Monooxygenase 33%
• Upregulation 16%
• Binding Affinity 16%
• DNA Binding 16%
• Protein Expression 16%
• Western Blot 16%
• Dopaminergic Neuron 16%
• Substantia Nigra Pars Compacta 16%
• Parkinson's Disease 16%
• B-Cell Lymphoma 16%
• Substantia nigra 16%
• Stereotypic Movement Disorder 16%
• Dorsolateral Striatum 16%
• Naphthoquinone 16%
• Glial Fibrillary Acidic Protein 16%

Neuroscience

• Neuroprotective Agent 100%
• Parkinson's Disease 100%
• Adenosine Monophosphate 100%
• Tetrahydropyridine 100%
• Protein Kinases 100%
• Nuclear Factor 100%
• Prothrombin 100%
• Astrocyte 50%
• Tyrosine Hydroxylase 33%
• Striatum 16%
• Substantia nigra 16%
• Naphthoquinone 16%
• Glial Fibrillary Acidic Protein 16%
• Dopaminergic Neuron 16%
• Western Blot 16%
• Protein Expression 16%
• Binding Affinity 16%
• DNA Binding 16%
• Substantia Nigra Pars Compacta 16%
• Stereotypic Movement Disorder 16%
• B Cell 16%
• Mouse Brain 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Nuclear Factor 100%
• Prothrombin 100%
• Adenosine Phosphate 100%
• MPTP-induced Parkinsonism 100%
• Neuroprotective Agent 100%
• Protein Kinases 100%
• 1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine 66%
• Tyrosine 3 Monooxygenase 33%
• Western Blot 16%
• B Cell Lymphoma 16%
• Dopamine Receptor Stimulating Agent 16%
• Motor Dysfunction 16%
• Tabebuia 16%
• Naphthoquinone 16%
• Parkinson's Disease 16%
• Glial Fibrillary Acidic Protein 16%